Cite
HARVARD Citation
Walz, J. et al. (2018). Favorable immune signature in CLL patients, defined by antigen-specific T-cell responses, might prevent second skin cancers. Leukemia & lymphoma. 59 (8), pp. 1949-1958. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Walz, J. et al. (2018). Favorable immune signature in CLL patients, defined by antigen-specific T-cell responses, might prevent second skin cancers. Leukemia & lymphoma. 59 (8), pp. 1949-1958. [Online].